HONG KONG, /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful $300 million first close of its Fund III.

Read more: https://www.prnewswire.com/news-releases/delos-capital-announces-300-million-first-close-of-its-third-life-sciences-fund-301482323.html